Forward Citations = 136

Loading Chart...

5 inventors (with patents filed for the assignee):

Richard K Cooper (5 out of 14 patents)

William C Fioretti (5 out of 16 patents)

Gary G Cadd (3 out of 3 patents)

4. Frederick M Enright (2 out of 13 patents)

5. Kenneth F De Boer (2 out of 2 patents)

5 patents: Sort by Forward Citations

1. 8283518 - Administration of transposon-based vectors to reproductive organs (2012-10-09),

2. 8236294 - Gene therapy using transposon-based vectors (2012-08-07),

3. 8071364 - Gene therapy using transposon-based vectors (2011-12-06),

4. 7608451 - Gene regulation in transgenic animals using a transposon-based vector (2009-10-27),

5. 7527966 - Gene regulation in transgenic animals using a transposon-based vector (2009-05-05),

Transgenrx, Inc. is a biotechnology company specializing in the development of innovative gene therapies for a range of genetic disorders. With a focus on personalized medicine, Transgenrx aims to revolutionize the field of gene therapy and improve the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#26 in Baton Rouge, LA

#181 in Louisiana

#50,165 in US

Baton Rouge, LA, United States of America

Transgenrx, Inc.